Alzheimer's Drugs Market 2030: Rise in Research and Developmental Activities to Boost the Market
Market Industry Reports (MIR) has published a new report titled "Global Alzheimers Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019-2030." According to the report, the global Alzheimers Drugs market was estimated to be over US $ 3.5 Bn in 2018. It is anticipated to grow at a CAGR of 7.2% from 2019 to 2030. The increasing pandemic of corona virus has stimulated maintaining hold on the clinical trials for the introduction of drugs for Alzheimer's disease. Only a few pharmaceutical companies are engrossed in the development and trials of modernized drugs that are more advanced than the drugs improving brain efficiency. Some drug manufacturing companies are also continuing their processes like enrollment and dosing for clinical trials.Major Key Players of the Alzheimer's Drugs Market are:
AC Immune, F. Hoffmann-La Roche, DAIICHI SANKYO COMPANY, Eli Lilly and Company, H. Lundbeck A/S, Eisai Co., Avanir Pharmaceuticals, Inc., Novartis AG, Janssen Global Services, LLC, AbbVie Inc. among others.
No comments:
Post a Comment